Robert Maronpot

Best Wishes to Our Departing Editor-in-Chief
Toxicol Pathol 2002 30: 1. [PDF]  

Leander Tryphonas and Paul-Georg Germann

Introduction and Summary of the Workshop "Drug Research Support: Selection and Early Development"
Toxicol Pathol 2002 30: 2-3. [PDF] [References]  

Gary L. Cockerell, James M. Mckim, JR, and Steven L. Vonderfecht

Strategic Importance of Research Support through Pathology
Toxicol Pathol 2002 30: 4-7. [Abstract] [PDF] [References]  

John E. Burkhardt, Anne M. Ryan, and Paul-Georg Germann

Practical Aspects of Discovery Pathology
Toxicol Pathol 2002 30: 8-10. [Abstract] [PDF] [References]  

Danielle Roman, Brigitte Greiner, Merdol Ibrahim, Dominique Pralet, and Paul-Georg Germann

Laser Technologies in Toxicopathology
Toxicol Pathol 2002 30: 11-14. [Abstract] [PDF] [References]  

Gary A. Boorman, Steven P. Anderson, Warren M. Casey, Roger H. Brown, Lynn M. Crosby, K. Gottschalk, Marilyn Easton, Hong Ni, and Kevin T. Morgan

Toxicogenomics, Drug Discovery, and the Pathologist
Toxicol Pathol 2002 30: 15-27. [Abstract] [PDF] [References]  

Jun Zhang, Eugene H. Herman, Alan Knapton, Douglas P. Chadwick, Virgil E. Whitehurst, John E. Koerner, Thomas Papoian, Victor J. Ferrans, and Frank D. Sistare

SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic, Electron Microscopic, and Immunohistochemical Studies
Toxicol Pathol 2002 30: 28-40. [Abstract] [PDF] [References]  

Gary M. Williams and Michael J. Iatropoulos

Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity
Toxicol Pathol 2002 30: 41-53. [Abstract] [PDF] [References]  

Ian Kimber and Rebecca J. Dearman

Immune Responses: Adverse Versus Non-Adverse Effects
Toxicol Pathol 2002 30: 54-58. [Abstract] [PDF] [References]  

Paul M.D. Foster and Barry S. Mcintyre

Endocrine Active Agents: Implications of Adverse and Non-Adverse Changes
Toxicol Pathol 2002 30: 59-65. [Abstract] [PDF] [References]  

Richard W. Lewis, Richard Billington, Eric Debryune, Armin Gamer, B. Lang, and Francis Carpanini

Recognition of Adverse and Nonadverse Effects in Toxicity Studies
Toxicol Pathol 2002 30: 66-74. [Abstract] [PDF] [References]  

Charlotte Keenan, Angela Hughes-Earle, Marvin Case, Barry Stuart, Stephen Lake, Charles Mahrt, William Halliwell, Richard Westhouse, Michael Elwell, Daniel Morton, Gerd Morawietz, Susanne Rittinghausen, Ulrich Deschl, and Ulrich Mohr

The North American Control Animal Database: A Resource Based on Standardized Nomenclature and Diagnostic Criteria
Toxicol Pathol 2002 30: 75-79. [Abstract] [PDF] [References]  

Ulrich Deschl, Birgit Kittel, Susanne Rittinghausen, Gerd Morawietz, Manfred Kohler, Ulrich Mohr, and Charlotte Keenan

The Value of Historical Control Data—Scientific Advantages for Pathologists, Industry and Agencies
Toxicol Pathol 2002 30: 80-87. [Abstract] [PDF] [References]  

Gary A. Boorman, Joseph K. Haseman, Michael D. Waters, Jerry F. Hardisty, and Robert C. Sills

Quality Review Procedures Necessary for Rodent Pathology Databases and Toxicogenomic Studies: The National Toxicology Program Experience
Toxicol Pathol 2002 30: 88-92. [Abstract] [PDF] [References]  

Cynthia Shackelford, Gerald Long, Jeffrey Wolf, Carlin Okerberg, and Ronald Herbert

Qualitative and Quantitative Analysis of Nonneoplastic Lesions in Toxicology Studies
Toxicol Pathol 2002 30: 93-96. [Abstract] [PDF] [References]  

Thomas L. Goldsworthy and Ronny Fransson-Steen

Quantitation of the Cancer Process in C57BL/6J, B6C3F1 and C3H/HeJ Mice
Toxicol Pathol 2002 30: 97-105. [Abstract] [PDF] [References]  

Melvin E. Andersen

The Use of Quantitative Histological and Molecular Data for Risk Assessment and Biologically Based Model Development
Toxicol Pathol 2002 30: 106-111. [Abstract] [PDF] [References]  

R. Julian Preston

Quantitation of Molecular Endpoints for the Dose-Response Component of Cancer Risk Assessment
Toxicol Pathol 2002 30: 112-116. [Abstract] [PDF] [References]  

Rashmi S. Nair, Roy L. Fuchs, and Sheila A. Schuette

Current Methods for Assessing Safety of Genetically Modified Crops as Exemplified by Data on Roundup Ready 1 Soybeans
Toxicol Pathol 2002 30: 117-125. [Abstract] [PDF] [References]  

Akihiro Hino

Safety Assessment and Public Concerns for Genetically Modified Food Products: The Japanese Experience
Toxicol Pathol 2002 30: 126-128. [Abstract] [PDF] [References]  

Bevan E.B. Moseley

Safety Assessment and Public Concern for Genetically Modified Food Products: The European View
Toxicol Pathol 2002 30: 129-131. [Abstract] [PDF] [References]  

Susan K. Harlander

Safety Assessments and Public Concern for Genetically Modified Food Products: The American View
Toxicol Pathol 2002 30: 132-134. [Abstract] [PDF]  

Carl Alden, Peter Smith, and Dan Morton

Application of Genetically Altered Models as Replacement for the Lifetime Mouse Bioassay in Pharmaceutical Development
Toxicol Pathol 2002 30: 135-138. [Abstract] [PDF] [References]  

Daniel Morton, Carl L. Alden, Arthur J. Roth, and Toshimi Usui

The Tg rasH2 Mouse in Cancer Hazard Identification
Toxicol Pathol 2002 30: 139-146. [Abstract] [PDF] [References]  

Eugenia Floyd, Peter Mann, Gerald Long, and Ricardo Ochoa

The Trp53 Hemizygous Mouse in Pharmaceutical Development: Points to Consider for Pathologists
Toxicol Pathol 2002 30: 147-156. [Abstract] [PDF] [References]  

Jan Willem Van Der Laan, Beatriz Silva Lima, and David Snodin

Alternatives Models in Carcinogenicity Testing—A European Perspective
Toxicol Pathol 2002 30: 157-159. [Abstract] [PDF] [References]  

Robert A. Ettlin and Joel R. Leininger

Toxicologic Pathology in the New Millennium
Toxicol Pathol 2002 30: 160-163. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.